Navigation Links
Knopp Neurosciences Initiates Phase 1 Clinical Trial of KNS-760704 in ALS Development Program
Date:9/24/2007

PITTSBURGH, Sept. 24 /PRNewswire/ -- Knopp Neurosciences Inc. ("Knopp") today announced the initiation of a Phase 1 clinical trial of KNS-760704, a small molecule therapy in development for the treatment of amyotrophic lateral sclerosis (ALS).

(Logo: http://www.newscom.com/cgi-bin/prnh/20070924/KNOPPLOGO )

This randomized, double-blind, placebo-controlled, single ascending dose study in healthy volunteers is being closely followed by a multiple ascending dose study in healthy subjects. Both studies are designed to evaluate the safety, tolerability and pharmacokinetics of KNS-760704 in human subjects.

"The initiation of Phase 1 represents a significant milestone in Knopp's efforts to develop a safe and effective therapy for a serious unmet medical need," said Michael Bozik, M.D., president and chief executive officer of Knopp. "We look forward to completing these safety studies and moving rapidly to advance the compound into initial clinical trials in ALS patients."

About KNS-760704

KNS-760704 is an orally administered small molecule in clinical development by Knopp for the treatment of amyotrophic lateral sclerosis (ALS). The drug is an optical enantiomer of a selective, high affinity dopamine agonist marketed in other neurological indications. Both KNS-760704 and the marketed agonist demonstrate neuroprotective properties independent of dopamine receptor activity, but KNS-760704 exhibits greatly reduced dopamine receptor affinity. This makes it possible to clinically evaluate the potential neuroprotective activity of KNS-760704 over a broad dose range.

About ALS

Amyotrophic lateral sclerosis (ALS), often called Lou Gehrig's disease, is a rapid, universally fatal neurodegenerative disorder characterized by progressive muscle weakness and wasting. ALS affects adults in the prime of life and creates a substantial burden for caregivers. U.
'/>"/>

SOURCE Knopp Neurosciences Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Solstice Neurosciences Presents Escalating Dose Study at International Congress in Istanbul, Turkey
2. Malvern initiates European user group meetings for chemical imaging
3. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
4. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... Mindray Medical International Limited (NYSE: MR ... medical devices worldwide, announced today that it has ... Report on Form 20-F that included audited financial ... electronic version of Mindray,s Annual Report on Form ... at  http://ir.mindray.com  or  http://www.sec.gov . Investors ...
(Date:4/16/2015)... MOUNTAIN VIEW, Calif. , April 16, 2015  Alexza ... its fiscal quarter ended March 31, 2015 on Wednesday, May ... The Company will also host an investor conference call and ... Time to provide a company update and discuss the financial ... Internet, go to www.alexza.com , under the "Investors" link.  ...
(Date:4/16/2015)... , April 16, 2015 Today, Kenneth C. ... & Co., Inc., was elected chairman of the Board of ... Board meeting, PhRMA,s president and CEO John J. Castellani ... 2016.  New Officers Elected to PhRMA Board ... succeeds Ian C. Read , chairman and CEO of ...
Breaking Medicine Technology:Mindray Files Annual Report on Form 20-F with the U.S. Securities and Exchange Commission 2Alexza to Report 2015 First Quarter Financial Results and Provide Corporate Update on Wednesday, May 6, 2015 2Alexza to Report 2015 First Quarter Financial Results and Provide Corporate Update on Wednesday, May 6, 2015 3Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman 2Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman 3Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman 4Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman 5
... 2012   Psyche Systems Corporation and Aperio ... offer the most advanced anatomic pathology information system ... pathologists can immediately access, manage, and evaluate their ... LIS via intuitive step-by-step workflows. ...
... treatment of the fermented soy germ-based nutritional supplement containing ... cholesterol and improved vascular stiffness, all factors that occur ... peer-reviewed study reported in a poster at the Women,s ... the first to provide evidence that a daily supplement ...
Cached Medicine Technology:Psyche Systems Corporation and Aperio® Announce Availability of Their Fully Integrated Anatomic Pathology System 2Soy-Based S-equol Supplement Reduces Metabolic Syndrome Risk Factors 2Soy-Based S-equol Supplement Reduces Metabolic Syndrome Risk Factors 3Soy-Based S-equol Supplement Reduces Metabolic Syndrome Risk Factors 4Soy-Based S-equol Supplement Reduces Metabolic Syndrome Risk Factors 5
(Date:4/17/2015)... 2015 Alcohol and Violence , The ... that drinking and driving has been the focus of ... time, the link between alcohol and crime received less ... violence and sexual assault, and their relationship to alcohol ... 5.3 million adults in America were drinking alcohol at ...
(Date:4/17/2015)... April 17, 2015 Consumers who prefer ... without modifications can now use the Insurance Pros USA ... insurance policy rates that are featured by leading companies ... plans that are offered are mixed between three of ... to 79. There are now term, universal and whole ...
(Date:4/17/2015)... April 17, 2015 Most dental patients ... restoration units are made overseas by foreign dental laboratories, ... labs remain unregulated in more than 40 states by ... National Association of Dental Laboratories has created the ... awareness among patients about the consequences that could be ...
(Date:4/17/2015)... The American College of Traditional Chinese Medicine (ACTCM) ... on April 29. The event will be held from 11 a.m. ... DeHaro St. in San Francisco, CA. , The agenda for the ... the DeHaro campus (room F), 11:10 a.m. – Introduction and ... Light lunch with current students, faculty and staff, 1 p.m. – ...
(Date:4/17/2015)... City, NJ (PRWEB) April 17, 2015 ... stored in the posterior pituitary and thought to help ... bonding between couples. To further substantiate this, new studies ... in the journal, Nature, and reported by Medical News ... have a powerful influence over maternal social behavior. The ...
Breaking Medicine News(10 mins):Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 2Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 3Health News:General Life Insurance Policy Rates Added to Quotation System at Insurance Website Online 2Health News:National Association Urges Transparency in Dental Industry 2Health News:American College of Traditional Chinese Medicine Hosts Open House 2Health News:Oxytocin Now Found to Help Diet Doc Patients Whose Weight Has Gotten out of Control Due to Emotional Eating Disorders 2Health News:Oxytocin Now Found to Help Diet Doc Patients Whose Weight Has Gotten out of Control Due to Emotional Eating Disorders 3
... infection known as bird flu in a 19-year-old soldier. ... Cheng, and said he was under treatment at a People's ... specify his unit or say which region he came from, ... ,Cheng developed symptoms of fever, coughing and pneumonia on May ...
... Boston Medical Center (BMC) and Boston University School of ... the human immunodeficiency virus (HIV), who also have ... hepatitis C virus (HCV). These findings appear in the ... ,Co-infection of HIV and HCV is a significant medical ...
... traffic injury, leads to neck pain, headache and other ... health care utilization. Although there are few effective ... that the type and intensity of treatment received shortly ... prognosis. A new study published in the June 2007 ...
... for vaccination of their stock against bird flu, but ... risks, experts warn. ,Nigeria to ... tackle H5N1.Through culling, quarantine, disinfecting and surveillance of affected ... disease incidence, according to Joseph Domenech, chief veterinary officer ...
... Mr Rob Mitchell, today said expensive private training courses ... for entry into medical school. ... as much as $1,700 to attend private training courses ... the Undergraduate Medical Admission Test (UMAT). ...
... actor Ryan Phillippes representatives are strongly denying the National Enquirer magazines ... other in the toilet at L.A. hot spot Les Deux ... singer star apparently followed Ryan to the washroom after he ... two groping and kissing each other!! The New York Daily source ...
Cached Medicine News:Health News:Persons With HIV and Alcohol Problems Co-infected With Hepatitis C 2Health News:Aggressive Treatment for Whiplash Does Not Promote Faster Recovery 2Health News:Concern Expressed Over Poor Quality Bird Flu Vaccine Used in Nigeria 2
The cardiac blanket is pre-positioned at the waist during prep, unrolled upon closure of the saphenous vein graft incision, and inflated post-bypass....
The cardiac access blanket helps maintain normothermia and allows unrestricted access to the patient....
The full access underbody blanket is positioned on the procedure table before the patient arrives to the room....
The cath lab blanket, designed for use in the Cardiac Cath Lab, surrounds the patient with warm air and allows unrestricted access to the femoral artery....
Medicine Products: